High cut-off hemodialysis and bortezomib-based therapy to rescue kidneys in myeloma-dependent cast nephropathy

被引：13
|
作者：
Sinisalo, Marjatta [1 ]
Silvennoinen, Raija [1 ]
Wirta, Ole [1 ]
机构：
[1] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2012年 / 87卷 / 06期
关键词：
PLASMA-EXCHANGE; RENAL-FAILURE; TRIAL;
D O I：
10.1002/ajh.23189
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [31] Therapeutic efficacy and cost effectiveness of high cut-off dialyzers compared to conventional dialysis in patients with cast nephropathy
    Curti, Adriano
    Schwarz, Albin
    Tomonaga, Yuki
    Ambuhl, Patrice
    [J]. SWISS MEDICAL WEEKLY, 2015, 145 : 2S - 2S
  • [32] Combined chemotherapy and high cut-off hemodialysis improve outcomes in, multiple myeloma patients with severe renal failure
    Hutchison, Colin A.
    Cook, Mark
    Basu, Supratik
    Cockwell, Paul
    Basnayake, Kolitha
    Bradwell, Arthur
    [J]. BLOOD, 2007, 110 (11) : 1056A - 1056A
  • [33] HIGH CUT-OFF EXTENDED-HOURS HAEMODIALYSIS FOR THE MANAGEMENT OF ACUTE KIDNEY INJURY FROM MYELOMA CAST NEPHROPATHY: RESULTS FROM A PROSPECTIVE VICTORIAN STUDY
    Ramessur, S.
    Kerr, P.
    Power, D.
    Filshie, R.
    Barker, N.
    Harrison, S.
    Langham, R. G.
    [J]. NEPHROLOGY, 2011, 16 : 57 - 57
  • [34] Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy
    Bridoux, Frank
    Arnulf, Bertrand
    Karlin, Lionel
    Blin, Nicolas
    Rabot, Nolwenn
    Macro, Margaret
    Audard, Vincent
    Belhadj, Karim
    Pegourie, Brigitte
    Gobert, Pierre
    Cornec Le Gall, Emilie
    Joly, Bertrand
    Karras, Alexandre
    Jaccard, Arnaud
    Augeul-Meunier, Karine
    Manier, Salomon
    Royer, Bruno
    Caillot, Denis
    Tiab, Mourad
    Delbes, Sebastien
    Suarez, Felipe
    Vigneau, Cecile
    Caillard, Sophie
    Arakelyan-Laboure, Nina
    Roos-Weil, Damien
    Chevret, Sylvie
    Fermand, Jean Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (23) : 2647 - +
  • [35] Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma
    Bumma, Naresh
    Dhakal, Binod
    Fraser, Raphael
    Estrada-Merly, Noel
    Anderson, Kenneth
    Freytes, Cesar O.
    Hildebrandt, Gerhard C.
    Holmberg, Leona
    Krem, Maxwell M.
    Lee, Cindy
    Lekakis, Lazaros
    Lazarus, Hillard M.
    Mian, Hira
    Murthy, Hemant S.
    Nathan, Sunita
    Nishihori, Taiga
    Parrondo, Ricardo
    Patel, Sagar S.
    Solh, Melhem
    Strouse, Christopher
    Vesole, David H.
    Kumar, Shaji
    Qazilbash, Muzaffar H.
    Shah, Nina
    D'Souza, Anita
    Sidana, Surbhi
    [J]. CANCER, 2023, 129 (14) : 2179 - 2191
  • [36] Rapid response to high cut-off haemodialysis and bortezomib therapy in a patient with acute renal failure and plasma cells dyscrasia
    Li-Cavoli, Gioacchino
    Di Bassiano, Francesco
    Tortorici, Calogera
    Bono, Luisa
    Ferrantelli, Angelo
    Giammarresi, Carlo
    Passantino, Rita
    Rotolo, Ugo
    [J]. NEFROLOGIA, 2014, 34 (05): : 688 - 688
  • [37] Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma
    Mai, Elias K.
    Hielscher, Thomas
    Bertsch, Uta
    Schlenzka, Jana
    Salwender, Hans J.
    Munder, Markus
    Gerecke, Christian
    Duehrsen, Ulrich
    Brossart, Peter
    Neben, Kai
    Hillengass, Jens
    Raab, Marc S.
    Merz, Maximilian
    Baertsch, Marc-Andrea
    Jauch, Anna
    Hose, Dirk
    Martin, Hans
    Lindemann, Hans-Walter
    Blau, Igor W.
    Scheid, Christof
    Weisel, Katja C.
    Goldschmidt, Hartmut
    [J]. LEUKEMIA, 2019, 33 (01) : 258 - 261
  • [38] Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma
    Elias K. Mai
    Thomas Hielscher
    Uta Bertsch
    Jana Schlenzka
    Hans J. Salwender
    Markus Munder
    Christian Gerecke
    Ulrich Dührsen
    Peter Brossart
    Kai Neben
    Jens Hillengass
    Marc S. Raab
    Maximilian Merz
    Marc-Andrea Baertsch
    Anna Jauch
    Dirk Hose
    Hans Martin
    Hans-Walter Lindemann
    Igor W. Blau
    Christof Scheid
    Katja C. Weisel
    Hartmut Goldschmidt
    [J]. Leukemia, 2019, 33 : 258 - 261
  • [39] Successful renal recovery from multiple myeloma-associated crystalline light chain cast nephropathy and accompanying acute kidney injury with early use of bortezomib-based therapy: a case report and literature review
    Miki, Kosuke
    Shimamura, Yoshinosuke
    Maeda, Takuto
    Moniwa, Norihito
    Ogawa, Yayoi
    Shimizu, Taku
    Hayashi, Toshiaki
    Sakai, Hajime
    Takizawa, Hideki
    [J]. CEN CASE REPORTS, 2023, 12 (01) : 56 - 62
  • [40] Successful renal recovery from multiple myeloma-associated crystalline light chain cast nephropathy and accompanying acute kidney injury with early use of bortezomib-based therapy: a case report and literature review
    Kosuke Miki
    Yoshinosuke Shimamura
    Takuto Maeda
    Norihito Moniwa
    Yayoi Ogawa
    Taku Shimizu
    Toshiaki Hayashi
    Hajime Sakai
    Hideki Takizawa
    [J]. CEN Case Reports, 2023, 12 : 56 - 62
12345